CurifyLabs key facts
as of Oct 2026- Developer of a compounding system designed to bring consistency, safety, and speed to personalized medicine preparation.The company offers proprietary software, GMP (Good Manufacturing…
- CurifyLabs is valued at approximately $31.2M as of Oct 2026 (last reported valuation).
- It has raised $11.3M; the latest was Equity Crowdfunding ($7.6M) in May 2025.
- Notable investors include European Innovation Council, European Union, Lifeline Ventures, Nordic Mentor Network For Entrepreneurship, Excedea Capital — 7 tracked in total.
- Status: Privately Held (backing).
CurifyLabs's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch CurifyLabs: the Monday email on marks, rounds and moves
CurifyLabs funding rounds
No funding rounds for CurifyLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CurifyLabs valuation
CurifyLabs's last reported valuation was $31.2 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
CurifyLabs investors
7 investors are on record for CurifyLabs, including European Innovation Council, European Union, Lifeline Ventures and Nordic Mentor Network For Entrepreneurship.
About CurifyLabs
Developer of a compounding system designed to bring consistency, safety, and speed to personalized medicine preparation.The company offers proprietary software, GMP (Good Manufacturing Practice)-manufactured excipients, and advanced 3D (three dimensional) printing technology, enabling hospitals and pharmacies to deliver precise, individualized treatments efficiently.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2021
- Employees
- 33
- Website
- curifylabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.